Novartis Expands Alliance with Science 37 to Advance Virtual Clinical Trials Program

Novartis has announced an additional strategic alliance with Science 37, a leader in decentralized clinical trial technology and design, to initiate up to 10 new clinical trials over the next three years. The studies will blend virtual and traditional models, with increasing degrees of decentralization towards a mostly "site-less" model.
Source: eHealth News EU - Category: Information Technology Tags: Featured Industry Business and Industry Source Type: news